- Home
- IOTR vs CVKD Comparison
IOTR vs CVKD Comparison
Compare IOTR & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- CVKD
- Stock Information
- Founded
- IOTR 2019
- CVKD 2022
- Country
- IOTR Singapore
- CVKD United States
- Employees
- IOTR N/A
- CVKD N/A
- Industry
- IOTR
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- IOTR
- CVKD Health Care
- Exchange
- IOTR NYSE
- CVKD Nasdaq
- Market Cap
- IOTR 29.5M
- CVKD 31.5M
- IPO Year
- IOTR 2025
- CVKD 2023
- Fundamental
- Price
- IOTR $0.92
- CVKD $16.88
- Analyst Decision
- IOTR
- CVKD Strong Buy
- Analyst Count
- IOTR 0
- CVKD 1
- Target Price
- IOTR N/A
- CVKD $32.00
- AVG Volume (30 Days)
- IOTR 2.1M
- CVKD 20.4K
- Earning Date
- IOTR 01-01-0001
- CVKD 05-08-2025
- Dividend Yield
- IOTR N/A
- CVKD N/A
- EPS Growth
- IOTR N/A
- CVKD N/A
- EPS
- IOTR N/A
- CVKD N/A
- Revenue
- IOTR $9,578,336.00
- CVKD N/A
- Revenue This Year
- IOTR N/A
- CVKD N/A
- Revenue Next Year
- IOTR N/A
- CVKD N/A
- P/E Ratio
- IOTR N/A
- CVKD N/A
- Revenue Growth
- IOTR 13.93
- CVKD N/A
- 52 Week Low
- IOTR $0.80
- CVKD $5.70
- 52 Week High
- IOTR $5.98
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- CVKD 50.50
- Support Level
- IOTR N/A
- CVKD $15.85
- Resistance Level
- IOTR N/A
- CVKD $17.33
- Average True Range (ATR)
- IOTR 0.00
- CVKD 1.44
- MACD
- IOTR 0.00
- CVKD 0.18
- Stochastic Oscillator
- IOTR 0.00
- CVKD 72.23
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.